§00 — Substances A–Z
Every medication
on the site.
Browse 858 AU-prescribable substances — medications with a brand name on the Australian market, a PBS listing, or a registered TGA Product Information document. If you know the name, the homepage search is faster, and search also covers substances outside this curated list (vaccines, OTC compounds, decommissioned drugs).
Prefer therapeutic classes? Browse by class → — antipsychotics, antidepressants, benzodiazepines and more, with the behaviour-support classes first.
A
79 substances- Abacavir— Nucleoside and nucleotide reverse transcriptase inhibitors
- Abatacept— Selective immunosuppressants
- Abemaciclib— Cyclin-dependent kinase (CDK) inhibitors
- Abiraterone— Other hormone antagonists and related agents
- Acalabrutinib— Bruton's tyrosine kinase (BTK) inhibitors
- Acamprosate— Anti-craving (alcohol)
- Acarbose— Alpha glucosidase inhibitors
- Acetazolamide— Carbonic anhydrase inhibitors
- Acetylcysteine— Mucolytics
- Aciclovir— Antiviral (herpes)
- Acitretin— Retinoids for treatment of psoriasis
- Adalimumab— Tumor necrosis factor alpha (TNF-alpha) inhibitors
- Adefovir dipivoxil— Nucleoside and nucleotide reverse transcriptase inhibitors
- Adenosine— Other cardiac preparations
- Afatinib— Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
- Aflibercept— Other antineoplastic agents
- Agomelatine— Melatonergic antidepressant
- Albendazole— Benzimidazole derivatives
- Albumin— Blood substitutes and plasma protein fractions
- Alectinib— Anaplastic lymphoma kinase (ALK) inhibitors
- Alemtuzumab— Monoclonal antibodies
- Alendronate— Bisphosphonate
- Alfentanil— Opioid anesthetics
- Alfuzosin— Alpha-adrenoreceptor antagonists
- Allopurinol— Xanthine oxidase inhibitor (gout)
- Alogliptin— Dipeptidyl peptidase 4 (DPP-4) inhibitors
- Alprazolam— Benzodiazepine
- Alprostadil— Prostaglandins
- Alteplase— Enzymes
- Amantadine— Adamantane derivatives
- Ambrisentan— Antihypertensives for pulmonary arterial hypertension
- Amfetamine— Centrally acting sympathomimetics
- Amifampridine— Other nervous system drugs
- Amikacin— Other antibiotics for topical use
- Amiodarone— Antiarrhythmics, class III
- Amisulpride— Atypical antipsychotic
- Amitriptyline— TCA
- Amivantamab— Other monoclonal antibodies and antibody drug conjugates
- Amlodipine— Calcium channel blocker
- Amorolfine— Other antifungals for topical use
- Amoxicillin— Penicillin antibiotic
- Amphotericin b— Antiinfectives and antiseptics for local oral treatment
- Ampicillin— Penicillins with extended spectrum
- Anagrelide— Other antineoplastic agents
- Anakinra— Interleukin inhibitors
- Anastrozole— Aromatase inhibitors
- Andexanet alfa— Antidotes
- Anidulafungin— Other antimycotics for systemic use
- Anifrolumab— Monoclonal antibodies
- Apalutamide— Anti-androgens
- Apixaban— DOAC
- Apomorphine— Drugs used in erectile dysfunction
- Apremilast— Selective immunosuppressants
- Aprepitant— Other antiemetics
- Arginine hydrochloride— Amino acids
- Aripiprazole— Atypical antipsychotic
- Armodafinil— Centrally acting sympathomimetics
- Arsenic trioxide— Other antineoplastic agents
- Asciminib— BCR-ABL tyrosine kinase inhibitors
- Asenapine— Atypical antipsychotic
- Aspirin— Salicylate analgesic / antiplatelet
- Atazanavir— Protease inhibitors
- Atenolol— Beta blocker
- Atezolizumab— PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
- Atomoxetine— ADHD non-stimulant
- Atorvastatin— Statin
- Atovaquone— Other agents against amoebiasis and other protozoal diseases
- Atracurium— Other quaternary ammonium compounds
- Atropine— Belladonna alkaloids, tertiary amines
- Auranofin— Gold preparations
- Avacopan— Complement inhibitors
- Avanafil— Drugs used in erectile dysfunction
- Avatrombopag— Other systemic hemostatics
- Avelumab— PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
- Axitinib— Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
- Azacitidine— Pyrimidine analogues
- Azathioprine— Other immunosuppressants
- Azithromycin— Macrolide
- Aztreonam— Monobactams
B
45 substances- Baclofen— Muscle relaxant (GABA-B agonist)
- Balsalazide— Aminosalicylic acid and similar agents
- Baricitinib— Janus-associated kinase (JAK) inhibitors
- Beclometasone— Inhaled corticosteroid
- Belantamab mafodotin— Other monoclonal antibodies and antibody drug conjugates
- Belimumab— Monoclonal antibodies
- Belzutifan— Other antineoplastic agents
- Bendamustine— Nitrogen mustard analogues
- Benralizumab— Other systemic drugs for obstructive airway diseases
- Benzatropine— Ethers of tropine or tropine derivatives
- Benzydamine— Other agents for local oral treatment
- Benzylpenicillin— Beta-lactamase sensitive penicillins
- Betahistine— Antivertigo preparations
- Betaine— Amino acids and derivatives
- Betamethasone— Topical corticosteroid (potent)
- Bevacizumab— VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors
- Bicalutamide— Anti-androgens
- Bimatoprost— Prostaglandin analogues
- Bimekizumab— Interleukin inhibitors
- Binimetinib— Mitogen-activated protein kinase (MEK) inhibitors
- Bisacodyl— Contact laxatives
- Bisoprolol— Beta blocker
- Bivalirudin— Direct thrombin inhibitors
- Bleomycin— Other cytotoxic antibiotics
- Blinatumomab— Other monoclonal antibodies and antibody drug conjugates
- Bortezomib— Proteasome inhibitors
- Bosentan— Antihypertensives for pulmonary arterial hypertension
- Botulinum toxin— Other muscle relaxants, peripherally acting agents
- Brentuximab vedotin— Other monoclonal antibodies and antibody drug conjugates
- Brexpiprazole— Atypical antipsychotic
- Brigatinib— Anaplastic lymphoma kinase (ALK) inhibitors
- Brimonidine— Other dermatologicals
- Brinzolamide— Carbonic anhydrase inhibitors
- Brivaracetam— Anticonvulsant
- Brolucizumab— Antineovascularisation agents
- Bromazepam— Benzodiazepine derivatives
- Bromhexine— Mucolytics
- Bromocriptine— Prolactine inhibitors
- Budesonide— Inhaled corticosteroid
- Bumetanide— Sulfonamides, plain
- Bupivacaine— Amides
- Buprenorphine— Opioid analgesic / partial agonist
- Bupropion— Atypical antidepressant
- Burosumab— Other drugs affecting bone structure and mineralization
- Busulfan— Alkyl sulfonates
C
82 substances- Cabazitaxel— Taxanes
- Cabergoline— Prolactine inhibitors
- Cabotegravir— Integrase inhibitors
- Cabozantinib— Other protein kinase inhibitors
- Caffeine— Other dermatologicals
- Calcitriol— Vitamin D and analogues
- Calcium chloride— Calcium
- Calcium folinate— Detoxifying agents for antineoplastic treatment
- Calcium gluconate— Calcium
- Candesartan— ARB
- Cannabidiol— Cannabinoid (CBD)
- Capecitabine— Pyrimidine analogues
- Capivasertib— Other protein kinase inhibitors
- Captopril— ACE inhibitors, plain
- Carbamazepine— Anticonvulsant / mood stabiliser
- Carbetocin— Oxytocin and analogues
- Carbimazole— Antithyroid
- Carbon dioxide— Medical gases
- Carboplatin— Platinum compounds
- Carboprost— Prostaglandins
- Carfilzomib— Proteasome inhibitors
- Carglumic acid— Amino acids and derivatives
- Cariprazine— Atypical antipsychotic
- Carmustine— Nitrosoureas
- Carvedilol— Beta blocker (alpha + beta)
- Caspofungin— Other antimycotics for systemic use
- Cefaclor— Second-generation cephalosporins
- Cefalexin— First-generation cephalosporin
- Cefazolin— First-generation cephalosporins
- Cefepime— Fourth-generation cephalosporins
- Cefoxitin— Second-generation cephalosporins
- Ceftazidime— Third-generation cephalosporins
- Ceftriaxone— Third-generation cephalosporins
- Cefuroxime— Second-generation cephalosporins
- Celecoxib— Other antineoplastic agents
- Cemiplimab— PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
- Ceritinib— Anaplastic lymphoma kinase (ALK) inhibitors
- Certolizumab pegol— Tumor necrosis factor alpha (TNF-alpha) inhibitors
- Cetrorelix— Anti-gonadotropin-releasing hormones
- Cetuximab— EGFR (Epidermal Growth Factor Receptor) inhibitors
- Chloral hydrate— Aldehydes and derivatives
- Chlorambucil— Nitrogen mustard analogues
- Chloramphenicol— Other antibiotics for topical use
- Chlorhexidine— Antiinfectives and antiseptics for local oral treatment
- Chlormethine— Nitrogen mustard analogues
- Chlorpromazine— Typical antipsychotic
- Chlortalidone— Sulfonamides, plain
- Cholecalciferol— Vitamin D and analogues
- Choriogonadotropin alfa— Gonadotropins
- Ciclesonide— Corticosteroids
- Ciclosporin— Calcineurin inhibitors
- Ciltacabtagene autoleucel— Antineoplastic cell and gene therapy
- Cinacalcet— Other anti-parathyroid agents
- Ciprofloxacin— Fluoroquinolone
- Cisatracurium— Other quaternary ammonium compounds
- Cisplatin— Platinum compounds
- Citalopram— SSRI
- Cladribine— Purine analogues
- Clarithromycin— Macrolide (CYP3A4 inhibitor — QT risk)
- Clevidipine— Dihydropyridine derivatives
- Clindamycin— Antiinfectives for treatment of acne
- Clobazam— Benzodiazepine
- Clobetasol— Topical corticosteroid (very potent)
- Clomifene— Ovulation stimulants, synthetic
- Clomipramine— TCA
- Clonazepam— Benzodiazepine
- Clonidine— Alpha-2 agonist
- Clopidogrel— Antiplatelet
- Clotrimazole— Antiinfectives and antiseptics for local oral treatment
- Clozapine— Atypical antipsychotic
- Cobimetinib— Mitogen-activated protein kinase (MEK) inhibitors
- Codeine— Opioid analgesic / antitussive
- Colchicine— Anti-gout
- Colestyramine— Bile acid sequestrants
- Corifollitropin alfa— Gonadotropins
- Cortisone— Glucocorticoids
- Crizotinib— Anaplastic lymphoma kinase (ALK) inhibitors
- Cyclizine— Piperazine derivatives
- Cyclopentolate— Anticholinergics
- Cyclophosphamide— Nitrogen mustard analogues
- Cyproterone— Anti-androgen
- Cytarabine— Pyrimidine analogues
D
54 substances- Dabigatran— DOAC
- Dabigatran etexilate— Direct thrombin inhibitors
- Dabrafenib— B-Raf serine-threonine kinase (BRAF) inhibitors
- Dacarbazine— Other alkylating agents
- Dantrolene— Dantrolene and derivatives
- Dapagliflozin— SGLT2 inhibitor
- Dapsone— Other anti-acne preparations for topical use
- Daptomycin— Other antibacterials
- Daratumumab— CD38 (Clusters of Differentiation 38) inhibitors
- Darbepoetin alfa— Other antianemic preparations
- Darolutamide— Anti-androgens
- Darunavir— Protease inhibitors
- Dasatinib— BCR-ABL tyrosine kinase inhibitors
- Daunorubicin— Anthracyclines and related substances
- Deferasirox— Iron chelating agents
- Deferiprone— Iron chelating agents
- Defibrotide— Other antithrombotic agents
- Degarelix— Other hormone antagonists and related agents
- Denosumab— RANKL inhibitor
- Desmopressin— Vasopressin analogue
- Desvenlafaxine— SNRI
- Deucravacitinib— Janus-associated kinase (JAK) inhibitors
- Dexamethasone— Glucocorticoid
- Dexamfetamine— ADHD stimulant
- Dexmedetomidine— Other hypnotics and sedatives
- Dexrazoxane— Detoxifying agents for antineoplastic treatment
- Diazepam— Benzodiazepine
- Diazoxide— Thiazide derivatives
- Diclofenac— NSAID
- Dicloxacillin— Beta-lactamase resistant penicillins
- Dienogest— Pregnadien derivatives
- Difelikefalin— Other therapeutic products
- Digoxin— Digitalis glycosides
- Diltiazem— Calcium channel blocker (non-DHP)
- Dimethyl fumarate— Other immunosuppressants
- Diroximel fumarate— Other immunosuppressants
- Disopyramide— Antiarrhythmics, class Ia
- Dobutamine— Adrenergic and dopaminergic agents
- Docetaxel— Taxanes
- Dolutegravir— Integrase inhibitors
- Donepezil— Cholinesterase inhibitor
- Dopamine— Adrenergic and dopaminergic agents
- Dorzolamide— Carbonic anhydrase inhibitors
- Dostarlimab— PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
- Dosulepin— Non-selective monoamine reuptake inhibitors
- Dothiepin— TCA
- Doxorubicin— Anthracyclines and related substances
- Doxycycline— Tetracycline
- Droperidol— Butyrophenone derivatives
- Dulaglutide— Glucagon-like peptide-1 (GLP-1) analogues
- Duloxetine— SNRI
- Dupilumab— Agents for dermatitis, excluding corticosteroids
- Durvalumab— PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
- Dutasteride— Testosterone-5-alpha reductase inhibitors
E
45 substances- Eculizumab— Complement inhibitors
- Edaravone— Other nervous system drugs
- Eflornithine— Other dermatologicals
- Elafibranor— Other drugs for bile therapy
- Eletriptan— Selective serotonin (5HT1) agonists
- Elotuzumab— Other monoclonal antibodies and antibody drug conjugates
- Elranatamab— Other monoclonal antibodies and antibody drug conjugates
- Eltrombopag— Other systemic hemostatics
- Empagliflozin— SGLT2 inhibitor
- Enalapril— ACE inhibitor
- Encorafenib— B-Raf serine-threonine kinase (BRAF) inhibitors
- Enfortumab vedotin— Other monoclonal antibodies and antibody drug conjugates
- Enoxaparin— Heparin group
- Entacapone— Other dopaminergic agents
- Entecavir— Nucleoside and nucleotide reverse transcriptase inhibitors
- Entrectinib— Other protein kinase inhibitors
- Enzalutamide— Anti-androgens
- Epcoritamab— Other monoclonal antibodies and antibody drug conjugates
- Ephedrine— Adrenergic and dopaminergic agents
- Epirubicin— Anthracyclines and related substances
- Eplerenone— Potassium-sparing diuretic
- Epoprostenol— Platelet aggregation inhibitors excl. heparin
- Eprosartan— Angiotensin II receptor blockers (ARBs), plain
- Eptifibatide— Platelet aggregation inhibitors excl. heparin
- Eptinezumab— Calcitonin gene-related peptide (CGRP) antagonists
- Eribulin— Other antineoplastic agents
- Erlotinib— Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
- Ertapenem— Carbapenems
- Erythromycin— Antiinfectives for treatment of acne
- Escitalopram— SSRI
- Esketamine— NMDA antagonist (treatment-resistant depression)
- Esmolol— Beta blocking agents, selective
- Esomeprazole— Proton pump inhibitor
- Estradiol— Natural and semisynthetic estrogens, plain
- Estriol— Natural and semisynthetic estrogens, plain
- Etanercept— Tumor necrosis factor alpha (TNF-alpha) inhibitors
- Ethambutol— Other drugs for treatment of tuberculosis
- Ethosuximide— Anticonvulsant
- Etoposide— Podophyllotoxin derivatives
- Etrasimod— Sphingosine-1-phosphate (S1P) receptor modulators
- Etravirine— Non-nucleoside reverse transcriptase inhibitors
- Everolimus— Mammalian target of rapamycin (mTOR) kinase inhibitors
- Evolocumab— Other lipid modifying agents
- Exemestane— Aromatase inhibitors
- Ezetimibe— Cholesterol absorption inhibitor
F
43 substances- Famciclovir— Nucleosides and nucleotides excl. reverse transcriptase inhibitors
- Famotidine— H2 antagonist
- Fampridine— Other nervous system drugs
- Faricimab— Antineovascularisation agents
- Febuxostat— Preparations inhibiting uric acid production
- Fedratinib— Janus-associated kinase (JAK) inhibitors
- Felodipine— Calcium channel blocker
- Fenfluramine— Centrally acting antiobesity products
- Fenofibrate— Fibrate
- Fentanyl— Opioid analgesic
- Ferrous fumarate— Iron bivalent, oral preparations
- Filgrastim— Colony stimulating factors
- Finasteride— 5-alpha-reductase inhibitor
- Finerenone— Aldosterone antagonists
- Fingolimod— Sphingosine-1-phosphate (S1P) receptor modulators
- Flecainide— Antiarrhythmics, class Ic
- Flucloxacillin— Beta-lactamase resistant penicillins
- Fluconazole— Antifungal
- Fludarabine— Purine analogues
- Fludrocortisone— Mineralocorticoids
- Flumazenil— Antidotes
- Flunitrazepam— Benzodiazepine
- Fluorescein— Colouring agents
- Fluorometholone— Corticosteroids
- Fluorouracil— Pyrimidine analogues
- Fluoxetine— SSRI
- Flutamide— Anti-androgens
- Fluticasone— Inhaled corticosteroid
- Fluticasone furoate— Corticosteroids
- Fluvoxamine— SSRI
- Folic acid— Vitamin B9
- Follitropin alfa— Gonadotropins
- Follitropin beta— Gonadotropins
- Follitropin delta— Gonadotropins
- Fondaparinux— Other antithrombotic agents
- Formoterol— Long-acting beta-2 agonist
- Foscarnet— Phosphonic acid derivatives
- Fosfomycin— Other antibacterials
- Fremanezumab— Calcitonin gene-related peptide (CGRP) antagonists
- Fruquintinib— Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
- Frusemide— Loop diuretic
- Fulvestrant— Anti-estrogens
- Furosemide— Sulfonamides, plain
G
33 substances- Gabapentin— Anticonvulsant / neuropathic
- Gadobutrol— Paramagnetic contrast media
- Galantamine— Cholinesterase inhibitor
- Galcanezumab— Calcitonin gene-related peptide (CGRP) antagonists
- Gallium (67ga) citrate— Other diagnostic radiopharmaceuticals for inflammation and infection detection
- Ganciclovir— Nucleosides and nucleotides excl. reverse transcriptase inhibitors
- Ganirelix— Anti-gonadotropin-releasing hormones
- Garadacimab— Drugs used in hereditary angioedema
- Gefitinib— Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
- Gemcitabine— Pyrimidine analogues
- Gemfibrozil— Fibrates
- Gemtuzumab ozogamicin— Other monoclonal antibodies and antibody drug conjugates
- Gentamicin— Other antibiotics for topical use
- Gilteritinib— Other protein kinase inhibitors
- Givosiran— Various alimentary tract and metabolism products
- Glatiramer acetate— Other immunostimulants
- Glibenclamide— Sulfonylureas
- Gliclazide— Sulfonylurea
- Glimepiride— Sulfonylurea
- Glipizide— Sulfonylureas
- Glofitamab— Other monoclonal antibodies and antibody drug conjugates
- Glucagon— Glycogenolytic hormones
- Glucose— Other irrigating solutions
- Glyceryl trinitrate— Organic nitrates
- Glycopyrronium— Antihidrotics
- Glycopyrronium— Antimuscarinic
- Glycopyrronium bromide— Synthetic anticholinergics, quaternary ammonium compounds
- Golimumab— Tumor necrosis factor alpha (TNF-alpha) inhibitors
- Goserelin— GnRH agonist
- Granisetron— Serotonin (5HT3) antagonists
- Griseofulvin— Antibiotics
- Guanfacine— ADHD non-stimulant
- Guselkumab— Interleukin inhibitors
H
14 substances- Haloperidol— Typical antipsychotic
- Heparin— Heparin group
- Hexaminolevulinate— Other diagnostic agents
- Human menopausal gonadotrophin— Gonadotropins
- Hyaluronidase— Enzymes
- Hydralazine— Hydrazinophthalazine derivatives
- Hydrochlorothiazide— Thiazide diuretic
- Hydrocortisone— Glucocorticoid
- Hydromorphone— Opioid analgesic
- Hydroxocobalamin— Vitamin B12 (cyanocobalamin and analogues)
- Hydroxycarbamide— Other antineoplastic agents
- Hydroxychloroquine— Aminoquinolines
- Hyoscine butylbromide— Antimuscarinic (antispasmodic)
- Hypromellose— Viscoelastic substances
I
36 substances- Ibrutinib— Bruton's tyrosine kinase (BTK) inhibitors
- Ibuprofen— NSAID
- Icatibant— Drugs used in hereditary angioedema
- Idarubicin— Anthracyclines and related substances
- Idelalisib— Phosphatidylinositol-3-kinase (Pi3K) inhibitors
- Iloprost— Platelet aggregation inhibitors excl. heparin
- Imatinib— BCR-ABL tyrosine kinase inhibitors
- Imiquimod— Antivirals
- Imlifidase— Selective immunosuppressants
- Inavolisib— Phosphatidylinositol-3-kinase (Pi3K) inhibitors
- Inclisiran— Other lipid modifying agents
- Indacaterol— Selective beta-2-adrenoreceptor agonists
- Indapamide— Thiazide-like diuretic
- Indometacin— Other cardiac preparations
- Infliximab— Tumor necrosis factor alpha (TNF-alpha) inhibitors
- Inotuzumab ozogamicin— CD22 (Clusters of Differentiation 22) inhibitors
- Insulin detemir— Insulins and analogues for injection, long-acting
- Interferon— Antivirals
- Interferon beta-1b— Interferons
- Interferon gamma— Interferons
- Ipilimumab— Other monoclonal antibodies and antibody drug conjugates
- Ipratropium— Short-acting muscarinic antagonist
- Iptacopan— Complement inhibitors
- Irbesartan— ARB
- Irinotecan— Topoisomerase 1 (TOP1) inhibitors
- Isoniazid— Hydrazides
- Isoprenaline— Adrenergic and dopaminergic agents
- Isosorbide dinitrate— Organic nitrates
- Isosorbide mononitrate— Organic nitrates
- Isotretinoin— Retinoids for topical use in acne
- Itraconazole— Antifungal
- Ivabradine— Other cardiac preparations
- Ivacaftor— Other respiratory system products
- Ivermectin— Other dermatologicals
- Ivosidenib— Isocitrate dehydrogenase (IDH) inhibitors
- Ixekizumab— Interleukin inhibitors
K
2 substancesL
40 substances- Labetalol— Alpha and beta blocking agents
- Lacosamide— Anticonvulsant
- Lamivudine— Nucleoside and nucleotide reverse transcriptase inhibitors
- Lamotrigine— Anticonvulsant / mood stabiliser
- Lanadelumab— Drugs used in hereditary angioedema
- Lanreotide— Somatostatin and analogues
- Lansoprazole— Proton pump inhibitors
- Lapatinib— Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
- Larotrectinib— Other protein kinase inhibitors
- Latanoprost— Prostaglandin analogue (glaucoma)
- Lebrikizumab— Agents for dermatitis, excluding corticosteroids
- Lecanemab— Other anti-dementia drugs
- Leflunomide— Dihydroorotate dehydrogenase (DHODH) inhibitors
- Lenalidomide— Other immunosuppressants
- Lenvatinib— Other protein kinase inhibitors
- Lercanidipine— Calcium channel blocker
- Letrozole— Aromatase inhibitors
- Leuprorelin— GnRH agonist
- Levetiracetam— Anticonvulsant
- Levonorgestrel— Progestogens
- Levothyroxine— Thyroid hormone
- Levothyroxine sodium— Thyroid hormones
- Lidocaine— Antiarrhythmics, class Ib
- Linagliptin— DPP-4 inhibitor
- Lincomycin— Lincosamides
- Linezolid— Other antibacterials
- Lipegfilgrastim— Colony stimulating factors
- Liraglutide— GLP-1 agonist
- Lisdexamfetamine— ADHD stimulant
- Lisinopril— ACE inhibitor
- Lithium— Mood stabiliser
- Lodoxamide— Other antiallergics
- Loperamide— Antipropulsives
- Lorazepam— Benzodiazepine
- Lorlatinib— Anaplastic lymphoma kinase (ALK) inhibitors
- Lumasiran— Various alimentary tract and metabolism products
- Lurasidone— Atypical antipsychotic
- Lutetium (177lu) oxodotreotide— Various therapeutic radiopharmaceuticals
- Lutropin alfa— Gonadotropins
- Lysine— Amino acids
M
54 substances- Macitentan— Antihypertensives for pulmonary arterial hypertension
- Magnesium sulfate— Osmotically acting laxatives
- Mannitol— Osmotically acting laxatives
- Maraviroc— Other antivirals
- Maribavir— Other antivirals
- Mavacamten— Other cardiac preparations
- Mecasermin— Somatropin and somatropin agonists
- Medroxyprogesterone— Progestogen
- Mefenamic acid— Fenamates
- Melatonin— Melatonergic hypnotic
- Meloxicam— Oxicams
- Melphalan— Nitrogen mustard analogues
- Memantine— NMDA receptor antagonist
- Mepolizumab— Other systemic drugs for obstructive airway diseases
- Mercaptopurine— Purine analogues
- Meropenem— Carbapenems
- Mesalazine— Aminosalicylic acid and similar agents
- Mesna— Mucolytics
- Metaraminol— Adrenergic and dopaminergic agents
- Metformin— Biguanide (oral antidiabetic)
- Methadone— Opioid agonist (dependence)
- Methotrexate— Folic acid analogues
- Methoxsalen— Psoralens for topical use
- Methoxy polyethylene glycol-epoetin beta— Other antianemic preparations
- Methyl aminolevulinate— Sensitizers used in photodynamic/radiation therapy
- Methylphenidate— ADHD stimulant
- Methylprednisolone— Glucocorticoid
- Metoclopramide— Prokinetic / antiemetic
- Metoprolol— Beta blocker
- Metronidazole— Nitroimidazole antibiotic
- Metyrapone— Tests for pituitary function
- Mianserin— Atypical antidepressant
- Miconazole— Antiinfectives and antiseptics for local oral treatment
- Midazolam— Benzodiazepine
- Midostaurin— Other protein kinase inhibitors
- Mifepristone— Progesterone receptor modulators
- Migalastat— Various alimentary tract and metabolism products
- Milrinone— Phosphodiesterase inhibitors
- Minocycline— Antiinfectives and antiseptics for local oral treatment
- Minoxidil— Pyrimidine derivatives
- Mirtazapine— NaSSA
- Mitomycin— Other cytotoxic antibiotics
- Mivacurium chloride— Other quaternary ammonium compounds
- Moclobemide— RIMA
- Modafinil— Wakefulness-promoting agent
- Mogamulizumab— Other monoclonal antibodies and antibody drug conjugates
- Molnupiravir— Nucleosides and nucleotides excl. reverse transcriptase inhibitors
- Momelotinib— Janus-associated kinase (JAK) inhibitors
- Mometasone— Topical corticosteroid (potent)
- Montelukast— Leukotriene receptor antagonist
- Morphine— Opioid analgesic
- Moxifloxacin— Fluoroquinolones
- Moxonidine— Imidazoline receptor agonists
- Mupirocin— Other antibiotics for topical use
N
33 substances- Nafarelin— Gonadotropin-releasing hormones
- Naloxone— Peripheral opioid receptor antagonists
- Naltrexone— Opioid antagonist (relapse prevention)
- Naproxen— NSAID
- Naratriptan— Selective serotonin (5HT1) agonists
- Natalizumab— Monoclonal antibodies
- Nebivolol— Beta blocker
- Nelarabine— Purine analogues
- Nemolizumab— Agents for dermatitis, excluding corticosteroids
- Neostigmine— Anticholinesterases
- Neratinib— Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
- Nevirapine— Non-nucleoside reverse transcriptase inhibitors
- Nicorandil— Other vasodilators used in cardiac diseases
- Nicotine— Nicotine replacement
- Nicotinic acid— Nicotinic acid and derivatives
- Nifedipine— Dihydropyridine derivatives
- Nilotinib— BCR-ABL tyrosine kinase inhibitors
- Nimodipine— Dihydropyridine derivatives
- Nintedanib— Other protein kinase inhibitors
- Niraparib— Poly (ADP-ribose) polymerase (PARP) inhibitors
- Nitisinone— Various alimentary tract and metabolism products
- Nitrazepam— Benzodiazepine
- Nitrofurantoin— Urinary antibacterial
- Nitroprusside— Nitroferricyanide derivatives
- Nitrous oxide— Other general anesthetics
- Nivolumab— PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
- Nizatidine— H2-receptor antagonists
- Norepinephrine— Adrenergic and dopaminergic agents
- Norethisterone— Progestogens
- Norfloxacin— Fluoroquinolones
- Nortriptyline— TCA
- Nusinersen— Other drugs for disorders of the musculo-skeletal system
- Nystatin— Antibiotics
O
29 substances- Obeticholic acid— Bile acids and derivatives
- Obinutuzumab— CD20 (Clusters of Differentiation 20) inhibitors
- Ocrelizumab— Monoclonal antibodies
- Octreotide— Somatostatin and analogues
- Odevixibat— Other drugs for bile therapy
- Ofatumumab— CD20 (Clusters of Differentiation 20) inhibitors
- Ofloxacin— Fluoroquinolones
- Olanzapine— Atypical antipsychotic
- Olaparib— Poly (ADP-ribose) polymerase (PARP) inhibitors
- Olmesartan— ARB
- Olmesartan medoxomil— Angiotensin II receptor blockers (ARBs), plain
- Olsalazine— Aminosalicylic acid and similar agents
- Omalizumab— Other systemic drugs for obstructive airway diseases
- Omeprazole— Proton pump inhibitor
- Onasemnogene abeparvovec— Other drugs for disorders of the musculo-skeletal system
- Ondansetron— 5-HT3 antagonist (antiemetic)
- Opicapone— Other dopaminergic agents
- Orlistat— Peripherally acting antiobesity products
- Oseltamivir— Neuraminidase inhibitors
- Osilodrostat— Anticorticosteroids
- Osimertinib— Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
- Oxaliplatin— Platinum compounds
- Oxazepam— Benzodiazepine
- Oxcarbazepine— Carboxamide derivatives
- Oxybutynin— Antimuscarinic (urinary)
- Oxycodone— Opioid analgesic
- Oxygen— Medical gases
- Oxytocin— Oxytocin and analogues
- Ozanimod— Sphingosine-1-phosphate (S1P) receptor modulators
P
76 substances- Paclitaxel— Taxanes
- Palbociclib— Cyclin-dependent kinase (CDK) inhibitors
- Paliperidone— Atypical antipsychotic
- Palonosetron— Serotonin (5HT3) antagonists
- Palovarotene— Other drugs for disorders of the musculo-skeletal system
- Panitumumab— EGFR (Epidermal Growth Factor Receptor) inhibitors
- Pantoprazole— Proton pump inhibitor
- Papaverine— Papaverine and derivatives
- Paracetamol— Analgesic / antipyretic
- Paraldehyde— Aldehydes and derivatives
- Parecoxib— Coxibs
- Paroxetine— SSRI
- Patent blue— Other diagnostic agents
- Patisiran— Other nervous system drugs
- Pazopanib— Other protein kinase inhibitors
- Pegcetacoplan— Complement inhibitors
- Pegfilgrastim— Colony stimulating factors
- Peginterferon alfa-2a— Interferons
- Peginterferon beta-1a— Interferons
- Pegvaliase— Enzymes
- Pegvisomant— Other anterior pituitary lobe hormones and analogues
- Pembrolizumab— PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
- Pemetrexed— Folic acid analogues
- Pemigatinib— Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
- Penicillamine— Penicillamine and similar agents
- Perampanel— Anticonvulsant
- Perazine— Phenothiazines with piperazine structure
- Perhexiline— Other non-selective calcium channel blockers
- Periciazine— Phenothiazines with piperidine structure
- Perindopril— ACE inhibitor
- Pertuzumab— HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
- Pethidine— Opioid analgesic
- Phenelzine— MAOI
- Phenobarbital— Barbiturate anticonvulsant
- Phenol— Sclerosing agents for local injection
- Phenoxybenzamine— Other peripheral vasodilators
- Phenoxymethylpenicillin— Beta-lactamase sensitive penicillins
- Phentermine— Centrally acting antiobesity products
- Phenylephrine— Adrenergic and dopaminergic agents
- Phenytoin— Anticonvulsant
- Pilocarpine— Other parasympathomimetics
- Pimecrolimus— Agents for dermatitis, excluding corticosteroids
- Pioglitazone— Thiazolidinediones
- Pirfenidone— Other immunosuppressants
- Piroxicam— Oxicams
- Pizotifen— Other antimigraine preparations
- Plerixafor— Other immunostimulants
- Polatuzumab vedotin— Other monoclonal antibodies and antibody drug conjugates
- Pomalidomide— Other immunosuppressants
- Ponatinib— BCR-ABL tyrosine kinase inhibitors
- Posaconazole— Triazole and tetrazole derivatives
- Potassium chloride— Potassium
- Pralatrexate— Folic acid analogues
- Pramipexole— Dopamine agonist
- Prasugrel— Platelet aggregation inhibitors excl. heparin
- Pravastatin— Statin
- Praziquantel— Quinoline derivatives and related substances
- Prazosin— Alpha-adrenoreceptor antagonists
- Prednisolone— Glucocorticoid
- Prednisone— Corticosteroids acting locally
- Pregabalin— Anticonvulsant / neuropathic
- Prilocaine— Amides
- Primidone— Barbiturates and derivatives
- Probenecid— Preparations increasing uric acid excretion
- Prochlorperazine— Phenothiazine antiemetic
- Progesterone— Pregnen (4) derivatives
- Promethazine— First-gen antihistamine
- Propantheline— Synthetic anticholinergics, quaternary ammonium compounds
- Propofol— Other general anesthetics
- Propranolol— Beta blocker
- Propylthiouracil— Thiouracils
- Protamine— Antidotes
- Prucalopride— Other drugs for constipation
- Pseudoephedrine— Sympathomimetics
- Pyrazinamide— Other drugs for treatment of tuberculosis
- Pyridostigmine— Anticholinesterases
Q
2 substances- Quetiapine— Atypical antipsychotic
- Quinine— Methanolquinolines
R
40 substances- Rabeprazole— Proton pump inhibitors
- Raloxifene— Selective estrogen receptor modulators
- Raltegravir— Integrase inhibitors
- Ramipril— ACE inhibitor
- Ranibizumab— Antineovascularisation agents
- Rasagiline— MAO-B inhibitor
- Ravulizumab— Complement inhibitors
- Reboxetine— NRI
- Regdanvimab— Antiviral monoclonal antibodies
- Remibrutinib— Selective immunosuppressants
- Remifentanil— Opioid anesthetics
- Repotrectinib— Other protein kinase inhibitors
- Ribociclib— Cyclin-dependent kinase (CDK) inhibitors
- Rifabutin— Antibiotics
- Rifampicin— Antimycobacterial
- Rifaximin— Antibiotics
- Rilpivirine— Non-nucleoside reverse transcriptase inhibitors
- Riluzole— Other nervous system drugs
- Riociguat— Antihypertensives for pulmonary arterial hypertension
- Ripretinib— Other protein kinase inhibitors
- Risankizumab— Interleukin inhibitors
- Risdiplam— Other drugs for disorders of the musculo-skeletal system
- Risedronate— Bisphosphonate
- Risperidone— Atypical antipsychotic
- Ritonavir— Protease inhibitors
- Rituximab— CD20 (Clusters of Differentiation 20) inhibitors
- Rivaroxaban— DOAC
- Rivastigmine— Cholinesterase inhibitor
- Rizatriptan— Triptan (migraine)
- Rocuronium bromide— Other quaternary ammonium compounds
- Romidepsin— Histone deacetylase (HDAC) inhibitors
- Romiplostim— Other systemic hemostatics
- Romosozumab— Other drugs affecting bone structure and mineralization
- Ropinirole— Dopamine agonist
- Ropivacaine— Amides
- Rosuvastatin— Statin
- Rotigotine— Dopamine agonist (transdermal)
- Roxithromycin— Macrolide
- Rozanolixizumab— Neonatal fragment crystallizable receptor (FcRn) inhibitors
- Ruxolitinib— Agents for dermatitis, excluding corticosteroids
S
43 substances- Sacituzumab govitecan— Other monoclonal antibodies and antibody drug conjugates
- Safinamide— Monoamine oxidase B inhibitors
- Salbutamol— Short-acting beta-2 agonist
- Salmeterol— Long-acting beta-2 agonist
- Sapropterin— Various alimentary tract and metabolism products
- Saxagliptin— Dipeptidyl peptidase 4 (DPP-4) inhibitors
- Secukinumab— Interleukin inhibitors
- Selegiline— MAO-B inhibitor
- Selexipag— Platelet aggregation inhibitors excl. heparin
- Selinexor— Other antineoplastic agents
- Selpercatinib— Other protein kinase inhibitors
- Selumetinib— Mitogen-activated protein kinase (MEK) inhibitors
- Semaglutide— GLP-1 agonist
- Sepiapterin— Various alimentary tract and metabolism products
- Sertraline— SSRI
- Sevelamer— Drugs for treatment of hyperkalemia and hyperphosphatemia
- Sevoflurane— Halogenated hydrocarbons
- Sildenafil— Drugs used in erectile dysfunction
- Silodosin— Alpha-adrenoreceptor antagonists
- Siltuximab— Interleukin inhibitors
- Simvastatin— Statin
- Siponimod— Sphingosine-1-phosphate (S1P) receptor modulators
- Sirolimus— Mammalian target of rapamycin (mTOR) kinase inhibitors
- Sitagliptin— DPP-4 inhibitor
- Sodium bicarbonate— Salt solutions
- Sodium chloride— Sodium
- Sodium phenylbutyrate— Various alimentary tract and metabolism products
- Sodium valproate— Mood stabiliser / anticonvulsant
- Solifenacin— Antimuscarinic (urinary)
- Somapacitan— Somatropin and somatropin agonists
- Somatrogon— Somatropin and somatropin agonists
- Somatropin— Somatropin and somatropin agonists
- Sonidegib— Hedgehog pathway inhibitors
- Sorafenib— Other protein kinase inhibitors
- Sotalol— Beta blocking agents, non-selective
- Spironolactone— Potassium-sparing diuretic
- Stiripentol— Other antiepileptics
- Sucroferric oxyhydroxide— Drugs for treatment of hyperkalemia and hyperphosphatemia
- Sugammadex— Antidotes
- Sulfasalazine— Aminosalicylic acid and similar agents
- Sumatriptan— Triptan (migraine)
- Sunitinib— Other protein kinase inhibitors
- Suxamethonium— Choline derivatives
T
69 substances- Tacrolimus— Agents for dermatitis, excluding corticosteroids
- Tadalafil— Drugs used in erectile dysfunction
- Tafamidis— Other nervous system drugs
- Talazoparib— Poly (ADP-ribose) polymerase (PARP) inhibitors
- Talquetamab— Other monoclonal antibodies and antibody drug conjugates
- Tamoxifen— Anti-estrogens
- Tamsulosin— Alpha-1 blocker (BPH)
- Tapentadol— Opioid analgesic
- Tebentafusp— Other antineoplastic agents
- Teclistamab— Other monoclonal antibodies and antibody drug conjugates
- Teduglutide— Various alimentary tract and metabolism products
- Teicoplanin— Glycopeptide antibacterials
- Telmisartan— ARB
- Temazepam— Benzodiazepine
- Temozolomide— Other alkylating agents
- Tenofovir disoproxil— Nucleoside and nucleotide reverse transcriptase inhibitors
- Tepotinib— Cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors
- Teprotumumab— Monoclonal antibodies
- Terbinafine— Other antifungals for topical use
- Terbutaline— Selective beta-2-adrenoreceptor agonists
- Teriflunomide— Dihydroorotate dehydrogenase (DHODH) inhibitors
- Teriparatide— Parathyroid hormones and analogues
- Terlipressin— Vasopressin and analogues
- Testosterone— 3-oxoandrosten (4) derivatives
- Tetrabenazine— Other nervous system drugs
- Tetracosactide— ACTH
- Tezepelumab— Other systemic drugs for obstructive airway diseases
- Thalidomide— Other immunosuppressants
- Thiamine— Vitamin B1
- Thiotepa— Ethylene imines
- Thrombin— Local hemostatics
- Thyrotropin— Tests for thyreoidea function
- Thyrotropin alfa— Thyrotropin
- Tiagabine— Anticonvulsant
- Tibolone— Other estrogens
- Ticagrelor— Platelet aggregation inhibitors excl. heparin
- Tigecycline— Tetracyclines
- Tildrakizumab— Interleukin inhibitors
- Timolol— Beta blocker (ophthalmic)
- Tiotropium— Long-acting muscarinic antagonist
- Tiotropium bromide— Anticholinergics
- Tirofiban— Platelet aggregation inhibitors excl. heparin
- Tislelizumab— PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
- Tobramycin— Other aminoglycosides
- Tocilizumab— Interleukin inhibitors
- Tofacitinib— Janus-associated kinase (JAK) inhibitors
- Tolvaptan— Vasopressin antagonists
- Topiramate— Anticonvulsant
- Toremifene— Anti-estrogens
- Toripalimab— PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
- Trabectedin— Other plant alkaloids and natural products
- Tramadol— Opioid analgesic
- Trametinib— Mitogen-activated protein kinase (MEK) inhibitors
- Trandolapril— ACE inhibitors, plain
- Tranexamic acid— Amino acids
- Tranylcypromine— MAOI
- Trastuzumab— HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
- Trastuzumab deruxtecan— HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
- Trastuzumab emtansine— HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
- Travoprost— Prostaglandin analogues
- Tremelimumab— Other monoclonal antibodies and antibody drug conjugates
- Treosulfan— Alkyl sulfonates
- Triamcinolone— Corticosteroids for local oral treatment
- Trientine— Various alimentary tract and metabolism products
- Trimethoprim— Folate antagonist
- Triptorelin— Gonadotropin releasing hormone analogues
- Trometamol— Solutions affecting the electrolyte balance
- Tropisetron— Serotonin (5HT3) antagonists
- Tucatinib— Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
U
4 substances- Ublituximab— Monoclonal antibodies
- Upadacitinib— Janus-associated kinase (JAK) inhibitors
- Ursodeoxycholic acid— Bile acids and derivatives
- Ustekinumab— Interleukin inhibitors
V
23 substances- Vadadustat— Other antianemic preparations
- Valaciclovir— Antiviral (herpes)
- Valganciclovir— Nucleosides and nucleotides excl. reverse transcriptase inhibitors
- Valsartan— ARB
- Vancomycin— Antibiotics
- Varenicline— Smoking cessation
- Vecuronium— Other quaternary ammonium compounds
- Vedolizumab— Monoclonal antibodies
- Velaglucerase alfa— Enzymes
- Vemurafenib— B-Raf serine-threonine kinase (BRAF) inhibitors
- Venetoclax— Other antineoplastic agents
- Venlafaxine— SNRI
- Verapamil— Calcium channel blocker (non-DHP)
- Vericiguat— Other vasodilators used in cardiac diseases
- Vigabatrin— Anticonvulsant
- Vildagliptin— Dipeptidyl peptidase 4 (DPP-4) inhibitors
- Vinorelbine— Vinca alkaloids and analogues
- Vismodegib— Hedgehog pathway inhibitors
- Vorasidenib— Isocitrate dehydrogenase (IDH) inhibitors
- Voriconazole— Triazole and tetrazole derivatives
- Vorinostat— Histone deacetylase (HDAC) inhibitors
- Vosoritide— Other drugs affecting bone structure and mineralization
- Vutrisiran— Other nervous system drugs
Z
12 substances- Zanubrutinib— Bruton's tyrosine kinase (BTK) inhibitors
- Zidovudine— Nucleoside and nucleotide reverse transcriptase inhibitors
- Zilucoplan— Complement inhibitors
- Zinc chloride— Electrolyte solutions
- Ziprasidone— Atypical antipsychotic
- Zolbetuximab— Other monoclonal antibodies and antibody drug conjugates
- Zoledronic acid— Bisphosphonate (annual IV)
- Zolmitriptan— Triptan (migraine)
- Zolpidem— Z-drug hypnotic
- Zonisamide— Anticonvulsant
- Zopiclone— Z-drug hypnotic
- Zuclopenthixol— Typical antipsychotic